Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer
Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer
Recruiting · NCT05346848 · Registry updated 2026-10-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 2 | 2026-10-08 | NCT05346848 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bayer | 178 |
| Institut Bergonié | 27 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Assitance Publique des Hôpitaux de Marseille - CHU La Timone | Marseille | France | 1 |
| CHP Saint-Grégoire | Saint-Grégoire | France | 2 |
| CHRU Besançon | Besançon | France | 3 |
| CHRU Brest - Hôpital Morvan | Brest | France | 1 |
| Clinique Pasteur | Toulouse | France | 26 |
| Hôpital de la Pitié Salpétrière | Paris | France | 2 |
| Institut Bergonie | Bordeaux | France | 53 |
| Institut de Cancérologie de l'Ouest - Site René Gauducheau | Saint-Herblain | France | 4 |
| IUCT Oncopôle | Toulouse | France | 1 |
| Sainte Catherine, Institut du Cancer Avignon-Provence | Avignon | France | 1 |